CALR and myelofibrosis: In addition, in patients with mutant (mut)CALR‐driven essential thrombocythaemia (ET) and myelofibrosis, there is a direct pro‐inflammatory effect of the mutant protein itself, as secreted mutCALR exaggerates cytokine production from normal monocytes.7